News

Update overview call topics Work Programmes 2019-2020

Published on | 6 years ago

Programmes
ERC RI MSCA ICT NMBP SPACE Risk Finance SME Instrument Health Food Energy Transport Climate/Environment Societies Security Widening SwafS Horizon 2020

There is  a new version available of our excel overview including the call topics of the recently updated Work Programmes: all data are downloaded from the Funding & Tenders portal's API-JSON files - this as a document on https://www.ncpflanders.be/general-horizon/horizon-2020-info

As a user you can update these data at any time yourself, make your own selections, use free text search etc. A manual of this excel file can be consulted by clicking the first icon (the information icon) in the file's quick access toolbar.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1824 articles available search in articles 

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.